BSE See NSE See 38,040.57
15.12 (0.04%)
Sectoral Outlook 2020 : The Good The Bad & The Ugly

Sectoral Outlook 2020 : The Good The Bad & The Ugly


It makes tremendous sense to increase appetite for equity when the stock prices fall. However, it is easy to get confused or even totally lost while deciding which sectors to focus on in such a crisis-driven situation. For sure all sectors are negatively impacted; however, some are impacted more than the rest. The DSIJ Research Team shares the outlook for various important sectors that will prove to be game-changers for the economy.

To read the entire article, you must be a DSIJ magazine subscriber.


Comments are only visible to subscribers.

DSIJ Mindshare

Glenmark to launch higher strength version of oral antiviral FabiFlu

Anthony Fernandes / Article rating: 4.7

Global pharma major, Glenmark Pharmaceuticals announced on Thursday that it is launching a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. Glenmark Pharmaceuticals was the first company in the country to have received the regulator’s approval for 400 mg dosage form.